More recently, the diabetic drug Actos (pioglitazone) was highlighted as a potential PD therapeutic, because the drug activates the PGC-1α protein pathway, and genes regulated by PGC-1α are known to be present at abnormally low levels in PD brain [36]. The gene discussed is PPARGC1A; the disease is Parkinson disease.